Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Thompson, Peyton J
COMBAT-HBV, NCT05705427: The COMBAT HBV Feasibility Trial	Recruiting	4	560	RoW	Tenofovir Disoproxil Fumarate 300 MG, Viread, Hepatitis B monovalent vaccine, Hepatitis B birth-dose vaccine, Engerix-B, Placebo	University of North Carolina, Chapel Hill, Doris Duke Charitable Foundation, Université Protestant au Congo, Abbott, Albert Einstein College of Medicine	Hepatitis B, Vertical Transmission of Infectious Disease	08/25	08/25
Mampunza, Samuel
COMBAT-HBV, NCT05705427: The COMBAT HBV Feasibility Trial	Recruiting	4	560	RoW	Tenofovir Disoproxil Fumarate 300 MG, Viread, Hepatitis B monovalent vaccine, Hepatitis B birth-dose vaccine, Engerix-B, Placebo	University of North Carolina, Chapel Hill, Doris Duke Charitable Foundation, Université Protestant au Congo, Abbott, Albert Einstein College of Medicine	Hepatitis B, Vertical Transmission of Infectious Disease	08/25	08/25